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Abstract
Introduction
Many viruses have been associated with human breast
cancers, including Epstein-Barr and Cytomegalovirus.
New evidence has revealed the frequent presence of high-
risk human papillomavirus (HPV) strains HPV16 and
HPV18 in breast carcinoma biopsies.  These findings raise
the question of whether HPV may infect developing can-
cers and mediate their growth and development, as was
recently observed with oral cancers.  The goal of this study
is to test the hypothesis that these high-risk HPV strains
are sufficient to significantly alter phenotypes of already
transformed human breast cancer cell lines.
Materials and methods
A series of in vitro experiments, including proliferation,
adhesion and viability assays, were used to quantify the
effects of HPV16 and HPV18 on the human breast cancer
cell lines, T-47D and MCF7, following transient transfec-
tion with the full length HPV virus. Normal breast and
fibroblast cell lines, MCF10A and Hs27, were used as non-
cancerous controls.
Results
HPV16 and HPV18 significantly inhibited proliferation
and adhesion of T-47D cells, although viability was not
affected.  Differential effects on proliferation were ob-
served in MCF7 cells; HPV16 inhibited proliferation,
while HPV18 stimulated proliferation.  No measurable
effects in adhesion or viability in MCF7 cells were ob-
served.  The phenotypic changes in T-47D and MCF7 cells
were associated with changes in mRNA expression of
caspase-2,-3 and -8, but not p53 or GAPDH.   No measur-
able changes in proliferation or viability were observed
following HPV transfection in the normal human breast
cell line, MCF10A, or the normal human fibroblast cell
line, Hs27, although adhesion was differentially affected.
Conclusions
Although HPV is a primary cause of virtually all cervi-
cal cancers, it is found as a concomitant infection in many
other tumors.  While HPV may initiate carcinogenesis in
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these tumors, recent studies suggest HPV may also modu-
late the progression or malignancy process in already trans-
formed cancers.  Determining what effects HPV has on
already transformed breast cancers may therefore become
an important step towards understanding the factors that
will lead to more effective treatment options for a signifi-
cant proportion of breast cancer patients.
Keywords: Breast cancer; Human papillomavirus
Introduction
Viruses, including Epstein-Barr, Cytomegalovirus, and Her-
pes simplex virus, have been implicated in the etiology of hu-
man breast cancers (Lawson et al., 2001; Lawson et al., 2006;
Tsai et al., 2007). Recent evidence now suggests that high-risk
human papillomavirus (HPV) strains HPV16 and HPV18, pri-
marily associated with cervical cancers, are also present in as
many as half of breast carcinoma biopsies (Kan et al., 2005; de
Villiers et al., 2005). HPV has been implicated as the causative
agent in many intraepithelial neoplasias and invasive squamous
cell carcinomas, with the HPV16 and HPV18 strains most fre-
quently observed, with HPV16 the most prevalent among non-
cervical cancers, such as oral and breast cancers (Herrero et al.,
2003; Munoz et al., 2003; Kan et al., 2005; Smith et al., 2007).
Infection with high-risk HPV plays a central role in the car-
cinogenesis and etiology of nearly all cases of cervical cancer,
therefore HPV may also function to transform oral and breast
tissue (Walboomers et al., 1999; Kreimer et al., 2005; Syrjanen
2005).  However, evidence from oral biopsies reveals a com-
paratively low presence of HPV in pre-malignant oral lesions
(10%), suggesting a role other than transformation (Kreimer et
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al., 2005; Syrjanen, 2005).  More recent evidence demonstrates
that high-risk HPV strains most commonly associated with these
HPV-positive oral cancers significantly alters in vitro growth
(Kingsley et al., 2006; Reddout et al., 2007).  When combined
with evidence that HPV is present only in a subset of oral can-
cers, these data imply that HPV infection may contribute to the
malignancy process in existing or developing cancers, rather
than acting as a primary factor for inducing carcinogenesis
(Gillison et al., 2000; van Houten et al., 2001).
The recent detection of HPV in a subset of breast cancers
raises the question of whether, in addition to a role in carcino-
genesis, HPV may also preferentially infect already developing
tumors and subsequently mediate their growth (Kan et al., 2005;
de Villiers et al., 2005). New evidence to determine the specific
role of HPV in breast carcinogenesis suggests HPV may be in-
volved in the transformation process in a majority of the cases
examined (Khan et al., 2008). However, these data further sug-
gest that in a significant subset of cases, other factors were likely
responsible for initiation of carcinogenesis and that HPV may
have preferentially infected these tumors, but not the surround-
ing tissue. Based upon this information, this study was designed
to understand what effects HPV may have on already existing
breast cancer cells.
Researchers hypothesize that several of the same risk factors
for developing cancer may also enhance the risk for acquiring
HPV infection. The main risk factors associated with breast can-
cer include family history of disease, levels of hormones such
as estrogen and progesterone, as well as cigarette smoking and
alcohol consumption (Dean, 2008; Mahoney et al., 2008). These
risk factors are not exclusive to breast cancer risk and may also
be strongly linked with HPV infection.
Interestingly, one recent study found that two HPV genes, E6
and E7, were sufficient to induce changes to metastatic pheno-
types in MCF7 and BT20 breast cancer cells, in vitro and in
vivo (Yasmeen et al., 2007a; Yasmeen et al., 2007b). To date,
no studies have yet examined the effects of the full-length HPV16
or HPV18 virus on the proliferative phenotype of established
breast cancers. This study is among the first to provide direct
evidence that elucidates the ability of HPV infection to alter the
proliferative phenotype of breast cancers in vitro.
Materials and Methods
Cell culture
The human breast cancer cell lines used in this study, MCF7
(HTB-22) and T-47D (HTB-133), as well as the non-tumori-
genic epithelial breast cell line MCF10A (CRL-10317) and nor-
mal human fibroblast cell line Hs27 (CRL-1634), were obtained
from American Type Culture Collection (ATCC: Manassas, VA).
In addition, CaSki (CRL-1550: epidermoid carcinoma, cervix)
and GH354 (CRL-13003: human cervical adenocarcinoma) were
also obtained from ATCC as HPV16 and HPV18 positive con-
trols, respectively. Hs27 fibroblast control and GH354 cervical
adenocarcinoma cells were maintained in Dulbecco’s Modified
Eagle’s Medium (DMEM) with 4 mM L-Glutamine, adjusted
to contain 3.7 g/L sodium bicarbonate and 4.5 g/L glucose, from
Hyclone (Logan, UT). T-47D and CaSki cells were maintained
in RPMI-1640 medium with 2mM L-Glutamine, adjusted to con-
tain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM
HEPES, and 1.0 mM sodium pyruvate. MCF7 cells were main-
tained in Minimum Essential Medium (MEM) with 2.00 mM
L-Glutamine with Earle’s Balanced Salts. MCF10A breast con-
trol cells were maintained in DME/F-12 with 2.50 mM L-
Glutamine and 15 mM HEPES buffer with 0.5 mg/ml hydro-
cortisone, 10 µg/mL EGF, 5 mg/ml insulin and 100 ng/ml chol-
era toxin. Media for all cell lines were supplemented with 10%
fetal bovine serum (FBS), and with 1% Penicillin (10,000 units/
mL)-Streptomycin (10,000 µg/ml) solution (HyClone), except
GH354 which was supplemented with 20% FBS and 1% Peni-
cillin-Streptomycin. Cell cultures were maintained in 75 cm2
BD Falcon tissue-culture treated flasks (Bedford, MA) at 37°C
and 5% CO2 in humidified chambers.
HPV screening
To determine if these  cell lines already harbor HPV, DNA
was isolated from 1.5 x 107 cells from each cell line using the
GenomicPrep DNA isolation kit (Amersham Biosciences:
Buckinghamshire, UK), using the procedure recommended by
the manufacturer.  To confirm the absence of HPV DNA in each
cell line prior to transfection and presence of HPV DNA in each
cell line post-transfection, PCR was performed with the Fisher
exACTGene complete PCR kit (Fisher Scientific: Fair Lawn,
NJ) and a Mastercycler gradient thermocycler (Eppendorf: Ham-
burg, Germany) using the following primers synthesized by
SeqWright (Houston, TX):
HPV18 forward primer, ATGGCGCGCTTTGAGGATCC;
HPV18 reverse primer, GCATGCGGTATACTGTCTCT;
HPV16 forward primer, ATGTTTCAGGACCCACAGGA;
HPV16 reverse primer, CCTCACGTCGCAGTAACTGT.
One µg of template DNA was used for each reaction. The
initial denaturation step ran for 1 minute at 94°C.  Thirty am-
plification cycles were run, consisting of 30 second denatur-
ation at 94°C, 60 seconds of annealing at 58°C, and 6.5 minutes
of extension at 68°C. Final extension was run for 5 minutes at
68°C. Reaction products were separated by gel electrophoresis
using Reliant 4% NuSieve® 3:1 Plus Agarose gels (Lonza:
Rockland, ME).  Bands were visualized by UV illumination of
ethidium-bromide-stained gels and captured using a Kodak Gel
Logic 100 Imaging System and 1D Image Analysis Software
(Eastman Kodak: Rochester, NY).
Transfection
MCF7 (HTB-22), T-47D (HTB-133), MCF10A (CRL-10317)
and Hs27 (CRL-1634) cells were transfected with HPV16 and
HPV18. Briefly, cells were seeded in 25cm2 BD Falcon tissue-
culture treated flasks in appropriate media (as described) and
allowed to achieve 70% confluence.  Cells were then transiently
transfected by adding 1 µg/ml of full-length HPV type 16, cloned
into the pBluescript SK-vector (ATCC #45113) or HPV type
18, cloned into the pBR322 vector (ATCC #45152). The trans-
fections were performed using the Stratagene Mammalian Trans-
fection Kit (La Jolla, CA) according to the manufacturer’s rec-
ommended protocol for CaPO4 transfection.  Mock transfectants
(mTF) of these four cell lines were also established by perform-
ing the same transfection protocol, but without using virus
(empty vector).
To test the effectiveness of the transient transfections, RNA
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was isolated from 1.5 x 107 cells of each of the experimental
and control cell lines, using ABgene Total RNA Isolation Re-
agent (Epsom, Surrey, UK) and the procedure recommended
by the manufacturer.  To quantify the expression of HPV mRNA,
RT-PCR was performed on total RNA using the ABgene Re-
verse-iT One-Step RT-PCR Kit (ReadyMix Version) and a
Mastercycler gradient thermocycler (Eppendorf: Hamburg,
Germany) using the HPV18 and HPV16 primers synthesized
by SeqWright (Houston, TX).
One µg of template (total) RNA was used for each reaction.
The reverse transcription step ran for 30 minutes at 47°C, fol-
lowed by denaturation for 2 minutes at 94°C. Thirty-five ampli-
fication cycles were run, consisting of 20 second denaturation
at 94°C, 30 seconds of annealing at 58°C, and 6.5 minutes of
extension at 72°C. Final extension was run for 5 minutes at 72°C.
Reaction products were separated by gel electrophoresis using
Reliant 4% NuSieve® 3:1 Plus Agarose gels (Lonza: Rockland,
ME). Bands were visualized by UV illumination of ethidium-
bromide-stained gels and captured using a Kodak Gel Logic
100 Imaging System and 1D Image Analysis Software (Eastman
Kodak: Rochester, NY). Quantitation of RT-PCR band densito-
metry and relative mRNA expression levels was performed us-
ing Adobe Photoshop (San Jose, CA) imaging software, Image
Analysis tools.
Proliferation
Proliferation assays were performed with MCF7, T-47D,
MCF10A, and Hs27 cells with the appropriate complete media
in Corning Costar 96-well assay plates (Corning, NY), using
HPV16 or HPV18 transfected cells, mock-transfected cells, and
non-transfected controls.  Cells were seeded at a concentration
of 1.2 x 104 cells per well and proliferation was measured over
three days at four time points (day 0 - day 3), as previously
described (Kingsley et al., 2006; Reddout et al., 2007). Cul-
tured cells were fixed at each time point, 0 hours (day 0), 24
hours (day 1), 48 hours (day 2), and 72 hours (day 3), using 50
µl of 10% buffered formalin and subsequently stained with crys-
tal violet 1% aqueous solution (Fisher Scientific: Fair Lawn,
NJ).  Relative absorbance was then measured at 630 nm using a
Bio-Tek ELx808 microplate reader (Winooski, VT) and data
were analyzed and graphed using Microsoft Excel (Redmond,
WA) and SPSS (Chicago, IL).  Three separate, independent rep-
lications of each experiment were performed.
Adhesion
Adhesion assays were performed at a concentration of 1.2 x
105 cells per well (100 µl of 1.2 x 106 cells/ml solution sus-
pended in serum-free DMEM, MEM, DME:F-12 or RPMI with
no additives) in uncoated Corning Costar 96-well assay plates
(Corning, NY)  as previously described (Plopper et al., 1995;
Wagner et al., 2002; Reddout et al., 2007). Cells were allowed
to attach for 30 minutes at 37°C with one modification to the
standard adhesion assay. The modified adhesion assays used in
this study eliminated the plate suspension step, in which non-
adherent cells are generally removed by suspending the plate
upside-down in a rotating tank of PBS, which greatly enhances
the sensitivity of this assay, as previously described (Kingsley
et al., 2006).  Following the incubation period, the cells were
fixed using 50 µl of 10% buffered formalin and subsequently
stained with crystal violet 1% aqueous solution (Fisher Scien-
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tific: Fair Lawn, NJ). Relative absorbance was then measured
at 630 nm using a Bio-Tek ELx808 microplate reader (Winooski,
VT) and data were analyzed and graphed using Microsoft Ex-
cel (Redmond, WA). Three separate, independent replications
of each assay were performed.
Viability
Prior to plating cells for adhesion and proliferation assays,
aliquots of trypsinized cells were stained using Trypan Blue
(Sigma: St. Louis, MO), and live cells were enumerated by count-
ing the number of Trypan-blue negative cells using a VWR Sci-
entific Counting Chamber (Plainfield, NJ) and a Zeiss Axiovert
40 inverted microscope (Gottingen, Germany). At each time
point (day 0-3), several wells were processed using the Trypan
stain, and live cells were enumerated using this procedure
(Felsher et al., 2000; Kingsley et al., 2002).
RT-PCR
RNA was isolated from 1.5 x 107 cells of each of the experi-
mental and control cell lines, using ABgene Total RNA Isola-
tion Reagent (Epsom, Surrey, UK) and the procedure recom-
mended by the manufacturer three days after transfection. RT-
PCR was performed on total RNA using the ABgene Reverse-
iT One-Step RT-PCR Kit (ReadyMix Version) and a
Mastercycler gradient thermocycler (Eppendorf: Hamburg,
Germany), as described above. The following primers for p53
(Vakifahmetoglu et al., 2006), caspase-2 and caspase-3 (Kugu
et al., 1998), caspase-8 (Ruiz-Ruiz et al., 2004), and glyceral-
dehyde-3- phosphate dehydrogenase (GAPDH) (Wolter et al.,
2003), synthesized by SeqWright (Houston, TX), were used:
p53 forward primer, ACCAGGGCAGCTACGGTTTC;
p53 reverse primer, CCTGGGCATCCTTGAGTTCC;
caspase-2 forward primer, TGGCATATAGGTTGCAGTCTC
GG;
caspase-2 reverse primer, TGTTCTGTAGGCTTGGGCA
GTTG;
caspase-3 forward primer, ACATGGAAGCGAATCAATG
GACTC;
caspase-3 reverse primer, AAGGACTCAAATTCTGTTG
CCACC;
caspase-8 forward primer, GATATTGGGGAACAACTGGAC;
caspase-8 reverse primer, CATGTCATCATCCAGTTTGCA;
GAPDH forward primer, ATCTTCCAGGAGCGAGATCC;
GAPDH reverse primer, ACCACTGACACGTTGGCAGT;
Bands were visualized by UV illumination of ethidium-bro-
mide-stained gels and captured using a Kodak Gel Logic 100
Imaging System and 1D Image Analysis Software (Eastman
Kodak: Rochester, NY).  Quantitation of RT-PCR band densi-
tometry was performed using Adobe Photoshop (San Jose, CA)
imaging software, Image Analysis tools.
Statistics
The differences between treatments were measured using a t
distribution (α=0.05). All samples were analyzed using two-
tailed t-tests, as departure from normality can make more of a
difference in a one-tailed than in a two-tailed t-test. As long as
the sample size is even moderate (>20 for each group), quite
severe departures from normality make little practical differ-
ence in the conclusions reached from these analyses (Hays,
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1994).  However, analyses involving multiple two sample t-tests
have a higher probability of Type I error, leading to false rejec-
tion of the null hypothesis, H0 (Hays, 1994). To confirm the
effects observed from these experiments and minimize the pos-
sibility of Type I error, further analysis of the data was facili-
tated with ANOVA using SPSS (Chicago, IL) to more accu-
rately assess relationships and statistical significance among and
between groups.
Results
HPV screening
To confirm that each cell line did not already harbor HPV,
DNA was isolated from cultured cells and PCR performed us-
ing primers specific for HPV16 and HPV18. In addition, two
HPV-positive cervical cancer cell lines, CaSki (HPV16) and
GH354 (HPV18), were included as positive controls (Figure
1). These results demonstrated that T-47D, MCF7, MCF10A,
and Hs27 were not found to contain endogenous HPV, while
confirming that CaSki and GH354 harbor HPV16 and HPV18,
respectively. Furthermore, the presence of HPV DNA was not
observed in mock transfectants, but could be verified post-trans-
fection.
Transfection
Effectiveness of the transient transfections and expression of
HPV mRNA was assessed by performing RT-PCR on total RNA
isolated from each cell line post-transfection and on the cell
lines known to harbor endogenous HPV (CaSki, GH354). These
results demonstrate that each HPV16-transfectants (Hs27-
HPV16 and MCF10A-HPV16), expressed roughly equivalent
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amounts of virus mRNA, while MCF7-HPV16 andT-47D-
HPV16 had slightly higher HPV mRNA expression profiles
(Figure 2). Comparison with CaSki HPV16-specific mRNA re-
veals that endogenous HPV expression was approximately
equivalent to the transfectants, although slightly lower among
the normal cell lines.  HPV18-transfectants (Hs27-HPV18,
MCF10A-HPV18, MCF7-HPV18, and T-47D-HPV18) ex-
pressed roughly equivalent amounts of virus mRNA, while com-
parison with GH354 HPV18-specific mRNA revealed that en-
dogenous HPV mRNA expression was slightly higher than that
of HPV18 transfectants.
Previous studies with oral cancers revealed that transfection
with the full-length HPV16 and HPV18 genome significantly
altered cellular proliferation, adhesion, and viability. To test the
hypothesis that HPV16 and HPV18 strains similarly alter the
phenotypes of breast cancer cells, in vitro assays were performed
following transfection with HPV16 and HPV18.
HPV inhibited proliferation and adhesion in T-47D cells
Transfection of T-47D cells with HPV16 resulted in lower
proliferation compared with non-transfected controls (-42%),
as did HPV18 (-39%) (p<0.01, n=216) (Figure 3A). Because
these analyses involved multiple two-sample t-tests and a higher
probability of Type I error, ANOVA was performed. This analysis
confirmed that both HPV16 and HPV18 inhibited cellular pro-
liferation in T-47D cells. T-47D-HPV16 proliferation was not
significantly different from T-47D-HPV18 proliferation, how-
ever, they were both significantly different from the mock and
non-transfected controls.
Based upon the results of the proliferation assay, we sought
to determine if this response correlated with measurable alter-
ations to cellular adherence or cellular viability.  Baseline T-
47D adhesion (without HPV) was significantly reduced by both
HPV16 (-16%; n=72, p<0.01) and HPV18 (-15%; n=72, p<0.01)
(Figure 3B), although measurements of cell survival and viabil-
ity revealed no significant differences between groups (Table
1).
Figure 1: HPV was detectable in experimental cell lines only after trans-
fection.
 (A) PCR from total DNA demonstrated that CaSki and GH354 contain HPV16
and HPV18 specific sequences, respectively. PCR from total DNA of experi-
mental cell lines confirms T-47D (A), MCF7, MCF10A and Hs27 (B) do not
harbor these HPV-specific sequences.  Following transfection with the full-
length HPV genome, each cell was found to contain HPV16 or HPV18 se-
quences, but not among mock transfectants (empty vector), such as T-47D mTF
(A) or MCF7 mTF (B).
Figure 2: HPV expression in vitro was comparable among transfectants.
RT-PCR confirmed HPV expression in all four cell lines (T-47D, MCF7,
MCF10A and Hs27) following HPV16 or HPV18 transfection. Scanning den-
sitometry measurement of relative endpoint RT-PCR band intensities from all
HPV18-transfectants were comparable, although lower than endogenous HPV
expression from GH354 cells (top). HPV mRNA expression in T-47D and MCF7
HPV16-transfectants were roughly equivalent to endogenous expression from
CaSki cells, and slightly higher than expression in normal cells, Hs27 and
MCF10A (bottom).
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HPV induced differential changes in MCF7 cell prolifera-
tion
Transfection of the MCF7 cells with HPV16 reduced prolif-
eration (-9.9%), while HPV18 stimulated proliferation (+10.4%)
in comparison to non-transfected controls (p<0.05, n=216) (Fig-
ure 4A). Two-tailed t-tests and one-way ANOVA confirmed this
differential response was statistically significant between both
experimental groups and the controls.
In contrast to the differential response in proliferation ob-
served following HPV transfection, no significant changes to
adhesion were observed in MCF7 cells (Figure 4B).  Analysis
of cellular viability revealed only minor, non-significant reduc-
tions in cellular viability between the HPV-transfected MCF7
cells and controls (Table 1).
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HPV induced minor changes to adhesion in the normal
breast cell line, MCF10A
To contextualize the HPV-induced changes in the setting of
breast cancer phenotypes that were observed, the responses of
a non-cancerous cell line were also assayed using the normal
human breast cell line, MCF10A. These experiments found no
significant differences between transfected (HPV16 or HPV18)
and non-transfected cells (Figure 5A). Two-tailed t-tests and
ANOVA were used to confirm that no statistical significance
was evident between these groups.
Although HPV exhibited no significant effects on the growth
or proliferation of MCF10A cells, cellular adhesion and viabil-
Figure 3: Proliferation and adhesion of T-47D cells was significantly in-
hibited by HPV16 or HPV18 in vitro.
HPV-transfected and control T-47D cells were plated in 96-well assay plates
with media containing 10% FBS and were allowed to proliferate for three days.
(A) HPV16 and HPV18 transfected cells exhibited reduced proliferation sig-
nificantly (-42%, -39%, respectively; p<0.01, n=216). (B) T-47D adhesion was
significantly inhibited by HPV16 (-15.9%) and HPV18 (-15.1%), as measured
by modified 30-minute adhesion assays (p<0.05, n=72).
Figure 4: Proliferation of MCF7 cells, but not adhesion, was differen-
tially influenced by HPV16 or HPV18 in vitro.
HPV-transfected and control MCF7 cells were plated in 96-well assay plates
with media containing 10% FBS and were allowed to proliferate for three days.
(A) HPV16-transfected cell proliferation was significantly inhibited (-9.9%),
while HPV18-transfected cell proliferation was significantly enhanced (+10.4%)
(p<0.05, n=216). (B) MCF7 cell adhesion was not significantly affected by
HPV16 (-0.6%) or HPV18 (+6.8%), as measured by modified 30-minute adhe-
sion assays (p>0.05, n=72).
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ity assays were also performed to assess if other behaviors were
affected. Unlike growth and proliferation, cellular adhesion of
MCF10A cells was significantly altered by HPV16 (+9.5%,
p<0.01, n=144) and HPV18 (+11.06%, p<0.01, n=144) com-
pared with non-transfected controls (Figure 5B), although no
differences in viability were observed (Table 1).
HPV induced minor changes to adhesion in the normal fi-
broblast cell line, Hs27
To further compare and contrast the HPV-induced phenotypic
that were observed between the cancerous and non-cancerous
cells tested, the responses of another non-cancerous cell line
were also assayed using the normal human fibroblast cell line,
Hs27. The results revealed no significant differences between
the proliferation of Hs27 cells transfected with HPV16 or
HPV18 and non-transfected Hs27 controls (p>0.05, n=72) (Fig-
ure 6A). Two-tailed t-tests confirmed no statistical differences
in proliferation were found between the groups (Hs27-HPV16,
p>.05; Hs27-HPV18, p>.05). ANOVA confirmed there were no
significant differences between or within the experimental and
control groups.
In addition to testing the effects of HPV16 and HPV18 on the
proliferation of Hs27 cells, cellular adhesion and viability were
assessed. Adhesion of the non-transfected Hs27 cells was sig-
nificantly inhibited by HPV16 (-19.25%, p>0.05, n=72) but not
by HPV18 (+13.12%, p>0.05, n=72) (Figure 6B). In addition,
no significant changes in viability were observed with Hs27-
HPV16 or HS27-HPV18 transfectants (Table 1).
RT-PCR
Researchers have established that the principle tumorigenic
activity of HPV early genes, including E6, may be the target-
ing, subsequent degradation, and down regulation of the tumor
suppressor p53 (Scheffner et al., 1990; Sun et al., 2008). Be-
cause damaged genes and other molecular pathways in cancer-
ous cells may involve deactivation of key tumor suppressors,
such as p53, total RNA was extracted from cells and relative
endpoint (RE) RT-PCR was performed to assess p53 expres-
sion in these cells (Figure 7). Wild type p53 expression was
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observed in both T-47D (Figure 7A) and MCF7 (Figure 7B)
breast cancer cell lines, confirming earlier observations (Ho et
al., 2005; Parssinen et al., 2008). The expression levels of p53
mRNA, however, were not significantly altered by HPV16 or
HPV18 transfection in either cell line over the time course of
these assays (Day 3 shown; Figure 7A, B), as was recently dem-
onstrated in some oral cancer cell lines transfected with HPV
(Chatelain et al., 2008).
Recently, other studies have suggested that HPV viral genome
amplification may also be dependent upon caspase-mediated
cleavage within the infected cells, which in turn may influence
differentiation and cellular replication rates (Moody et al., 2007;
Post-transfection viability:   Baseline 
viability 
(non-
transfected) HPV16 
% 
change HPV18 
% 
change 
T-47D: 
96.4% 
(136/141) 
94.9% 
(195/205) 
-1.5% 
 
96.9% 
(157/162) 
+0.5% 
 
MCF7: 
100% 
(110/110) 
96.2% 
(315/325) 
-3.8% 
 
97% 
(198/204) 
-3.0% 
 
MCF10A: 
95.5% 
(173/181) 
89.9% 
(251/279) 
-5.6% 
 
91.5% 
(257/281) 
-4.0% 
 
Hs27: 
92.4% 
(208/226) 
87.3% 
(180/203) 
-5.1% 
 
95.1% 
(202/212) 
+2.7% 
 
Table 1: Cell viability in control and HPV-transfected cells.
Figure 5: HPV16 and HPV18 did not significantly alter MCF10A pheno-
types in vitro.
HPV-transfected and control MCF10A cells were plated in 96-well assay plates
with media containing 10% FBS and were allowed to proliferate for three days.
(A) HPV16- and HPV18-transfected cell proliferation was similar and not sig-
nificantly different from control cells (p>0.05, n=216). (B) MCF10A cell adhe-
sion was significantly enhanced by HPV16 (+9.5%) and HPV18 (+11.06%), as
measured by modified 30-minute adhesion assays (p<0.05, n=72).
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Coelho et al., 2008). (RE) RT-PCR was performed to deter-
mine if the effects of HPV16 and HPV18 transfection on these
cells correlated with differential expression of specific mem-
bers of the caspase family (Figure 7). In sharp contrast to p53
expression, marked increases in the expression of caspase-2, -
3, and-8 mRNA were observed in T-47D cells following HPV
transfection (Figure 7A). MCF7 cells, however, exhibited dif-
ferential responses to HPV transfection (Figure 7B), with HPV16
reducing and HPV18 stimulating caspase-2 mRNA expression
levels.   Interestingly, caspase-3 mRNA expression was unde-
tectable in this cell line and no significant changes in caspase-8
mRNA were observed in either cell line. No changes to mRNA
expression levels were observed in Hs27 or MCF10A cells (data
not shown).
To quantify the relative changes in mRNA expression levels
from the experimental and control groups, scanning densitom-
etry was performed. Specifically, HPV16 increased expression
of the apoptosis initiators caspase-2 (+28.55%) and caspase-3
(+47.55%), as well as the apoptosis-effector caspase-8
Journal of Cancer Science & Therapy  - Open Access
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(+32.02%) in T-47D cells; HPV18 also increased expression of
caspase-2 (+26.37%), caspase-3 (+53.87%) and caspase-8
(+50.63%), revealing that caspase mRNA expression levels were
significantly altered by HPV16 or HPV18, but not levels of
p53 or GAPDH mRNA. The differential response of MCF7 cells,
however, revealed that HPV16 reduced expression of caspase-
2 (-14.5%), while HPV18 increased caspase-2 mRNA expres-
sion (+18.34%).
Discussion
Persistent infection with high-risk, oncogenic HPV strains has
been firmly established as the primary cause of virtually all cases
of cervical cancer (Walboomers et al., 1999; Castellsague, 2008).
In contrast, ample evidence now confirms that HPV is present
in a subset of oral cancers and more recently, in breast cancers
that may be unrelated to carcinogenesis (Kan et al., 2005; de
Villiers et al., 2005; Kreimer et al., 2005; Syrjanen, 2005). Some
evidence now suggests that HPV infection in these tissues may
contribute to, rather than directly cause, the malignancy or trans-
formation process.
For example, a recent study explored the potential roles of
HPV in breast cancer patients.  This study revealed that ap-
proximately two-thirds of normal epithelial tissue samples taken
from sites adjacent to HPV16-expressing breast carcinomas also
contained HPV16 DNA (Khan et al., 2008), suggesting that HPV
may have induced transformation in the larger subset of these
Figure 6: HPV16 and HPV18 did not significantly alter Hs27 phenotypes
in vitro.
HPV-transfected and control Hs27 cells were plated in 96-well assay plates
with media containing 10% FBS and were allowed to proliferate for three days.
(A) HPV16- and HPV18-transfected cell proliferation was similar and not sig-
nificantly different from control cells (p>0.05, n=216). (B) Hs27 cell adhesion
was significantly inhibited by HPV16 (-19.25%), but not by HPV18 (-13.12%),
as measured by modified 30-minute adhesion assays (p>0.05, n=72).
Figure 7: T-47D and MCF7 mRNA analysis.
RT-PCR was performed on total RNA extracted from 107 T-47D (A) and MCF7
(B) cells at 24 and 48 hours (data not shown), and 72 hours. Relative endpoint
(RE) RT-PCR revealed that p53 and GAPDH expression levels remained rela-
tively constant pre- and post-transfection in both cell lines. HPV16 and HPV18
significantly enhanced expression of caspase-2, -3 and -8 in T-47D cells (A),
while no significant changes were noted in MCF7 cells (B). Note: caspase-3
mRNA was undetectable in MCF7 cells at all time points.  Scanning densitom-
etry was performed from RE-RT-PCR results, revealing HPV16 increased ex-
pression of caspase-2 (+28.55%), caspase-3 (+47.55%), and caspase-8
(+32.02%) in T-47D cells; MCF7 cells exhibited a differential response, with
HPV16 reducing expression of caspase-2 (-14.5%) and HPV18 increasing
caspase-2 mRNA expression (+18.34%); no significant measurable differences
in caspase-8 mRNA were evident.
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breast cancer patients. However, these data also provide strong
evidence that HPV was not involved in the etiology of the smaller
subset, which did not contain any discernable evidence of a lo-
calized HPV infection. Although many studies suggest that spe-
cific oncogenic HPV strains may be present in up to half of
breast cancer biopsies, few studies to date have investigated the
possibility that HPV infection may, in fact, mediate specific phe-
notypes associated with the malignancy process (Kan et al.,
2005; de Villiers et al., 2005). This study is among the first to
provide direct evidence that HPV is capable of modulating the
proliferative phenotypes of existing breast cancers.
Based upon results from other studies demonstrating HPV
mediates the proliferative phenotypes of oral cancers (Kingsley
et al., 2006; Reddout et al., 2007), the current study investi-
gated whether high-risk HPV16 and HPV18 strains induce sig-
nificant and measurable changes in breast cancer phenotypes,
including proliferation. The results indicated that either HPV
strain is sufficient to alter growth rates in both of the breast
cancer cell lines examined, but not normal cells. Although pre-
vious evidence has demonstrated that HPV16 and HPV18 were
sufficient to immortalize a normal human mammary epithelial
cell line, these studies were not designed to explore the possi-
bility that HPV might have differential effects in already trans-
formed cells (Band et al. 1990). Moreover, previous studies of
HPV-mediated effects on normal cell lines, including human
foreskin keratinocytes and normal breast tissues, were designed
to assay HPV-induced immortalization, or escape from senes-
cence, rather than the relative proliferation or turnover rates of
these cells in culture (Band et al., 1990; Hawley-Nelson et al.,
1999). Finally, new evidence is emerging which suggests HPV
infection in some oral cancers may actually increase patient
survival under certain conditions, suggesting a clinical correla-
tion with these differential proliferative responses (Fischer et
al., 2009; Jung et al., 2009).
The experimental design of this study was employed specifi-
cally to reveal the presence of differential responses, not only
between the cell lines, but also between different HPV strains
within the same cell line.  These data now suggest complex in-
ter-relationships between the effects of HPV infection and in-
trinsic cellular or cytogenetic differences.  Moreover, these re-
sults bear some resemblance to previous work from this labora-
tory that demonstrated these high risk HPV strains do not elicit
equivalent responses among all oral cancer cell lines tested, and
that different HPV strains may inhibit or increase cell prolifera-
tion within the same cell line (Reddout et al., 2007).
HPV elicits cellular responses as part of the transformation
process in cervical epithelia, yet those specific responses were
not observed in the breast cancer cell lines in this study. For
instance, HPV viral replication proteins influence cellular pro-
liferation in most cervical cancers by inactivating degrading,
and subsequently down regulating tumor suppressor proteins,
such as p53 (Scheffner et al., 1990; Werness et al., 1990). How-
ever, in this study, HPV transfection did not significantly alter
p53 expression in either breast cancer cell line, which may seem
at odds with the evidence from cervical cancers.
Recent work now confirms that many viruses have evolved
alternative mechanisms to inhibit p53 function.  For example,
p53 deactivation may occur via site-specific serine phosphory-
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lation in some cells without mRNA down regulation (Shin et
al., 2006; Sun et al., 2008). Data indicating that wild-type p53
expression was not reduced by HPV transfection in these breast
cancers might suggest that HPV in these cell lines may instead
utilize other mechanisms, such as phosphorylation-mediated in-
activation of p53. Future studies are now planned to explore
these potential mechanisms.
Although deregulation or deactivation of p53 and other tu-
mor suppressors may be critical to the mechanisms of the HPV
life cycle, other work has demonstrated that HPV viral genome
amplification may also be dependent upon caspase-mediated
functions within infected cells (Moody et al., 2007; Coelho et
al., 2008). These studies reveal that the productive viral life
cycle of HPV is significantly enhanced by caspase-mediated
cleavage that may, in fact, be integral to the HPV viral life cycle.
Aside from their incidental involvement in the HPV life cycle,
caspases function primarily as potent activators of cellular
apoptosis and are known to inhibit cellular proliferation. Caspase
up-regulation and proliferation inhibition have also been ob-
served in previous work using cervical cancer cells (Moody et
al., 2007; Coelho et al., 2008; Singh and Singh, 2008). Intrigu-
ingly, the anti-cancer mechanism of Taxol (Paclitaxel), a potent
treatment for ovarian, lung and breast cancers, was recently
determined to involve activation of members of the caspase fam-
ily, more specifically caspase-8 (Lee et al., 2005).
Despite the growing evidence that high-risk HPV strains are
present in many breast tumors, few studies have examined the
ability of HPV to modulate cellular phenotypes in these can-
cers. Although epidemiologic studies suggest other risk factors,
such as genetic predisposition and tobacco or alcohol use, are
likely responsible for breast oncogenesis, new evidence sug-
gests concomitant HPV infection may significantly alter tumor
growth. This study provides direct evidence that HPV16 and
HPV18 can modulate the proliferative phenotypes in existing
breast cancer cell lines, although more research is needed to
understand the complex inter-relationships between the observed
effects of HPV infection and specific intrinsic or cytogenetic
differences that control this phenomenon. Determining the ef-
fects of HPV on already transformed breast cancers is thus an
important step towards understanding the factors that will ulti-
mately lead to more accurate prognosis and more effective treat-
ment options for breast cancer patients with concomitant HPV
infections.
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